retatrutide triple agonist obesity trial 🚨 Today, retatrutide, the GIP/GLP-1/glucagon agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent and type 2 diabetes. 📊 Mean body weight change at 80 weeks: ⬇️ 🚨 Retatrutide TRIUMPH-1 Phase 3

Suppressed macrophage infiltration followed by reduced macrophage foam cell formation by active forms of GLP-1 and GIP was demonstrated by Nagashima M, et al

This price tag often forces patients to choose between their health goals and their financial stability, a decision nobody should have to make

Related Reading Glp 1 For Weight Loss 2 Glp 1 Weight Loss Before And After Glp 1 Dosage For Weight Loss Cheapest Glp 1 Without Insurance Online Plexusdx Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims

The Ariad standard requires evidence that the inventor possessed the specific claimed subject matter not merely that they were working in the relevant field